Miami, FLNCT05567406Now EnrollingIRB Ready

Chronic Graft Versus Host Disease Clinical Trial in Miami, FL

Access cutting-edge chronic graft versus host disease treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by Kadmon, a Sanofi Company

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions...

Expert Care in Miami

Access chronic graft versus host disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic graft versus host disease treatment provided free

Apply for This Miami Location

Check if you qualify for this chronic graft versus host disease clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Chronic Graft Versus Host Disease Study in Miami

The purpose of this study is to measure safety and efficacy of oral belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander male and female participants with cGVHD who have previously been treated with at least 2 prior lines of systemic therapy aged 12 years and above. The duration of participants participation will be up to 4 weeks for screening, treatment until clinically significant progression of disease, and 4 weeks of safet

Sponsor: Kadmon, a Sanofi Company

Who Can Participate

Inclusion Criteria

Participants are included in the study if any of the following criteria apply:
Participant is Black or African American, or American Indian or Alaska Native, or Native Hawaiian or Other Pacific Islander by self-identification.
Previously received at least 2 and not more than 5 lines of systemic therapy for cGVHD.
Receiving glucocorticoid therapy with a stable dose over the 2 weeks prior to screening.
Have persistent cGVHD manifestations and systemic therapy is indicated.
Karnofsky (if aged ≥ 16 years) / Lansky (if aged \< 16 years) Performance Score of ≥ 60.
At least 12 years of age; weight ≥ 40 kilograms (kg).
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 x upper limit of normal (ULN).
Total bilirubin ≤ 1.5 x ULN.
Contraception (with double contraception methods) for male and female participants; not pregnant or breastfeeding for female participants
Capable of giving signed informed consent.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT05567406) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Graft Versus Host Disease Treatment Options in Miami, FL

If you're searching for chronic graft versus host disease treatment options in Miami, FL, this clinical trial (NCT05567406) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic graft versus host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic graft versus host disease clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Miami, FL

See all atrial fibrillation clinical trials recruiting in Miami — not just this study.

Browse Atrial Fibrillation Trials in Miami

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL